Stock research.
Every claim sourced.
Evidence-based equity research for retail investors. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every number traces to a primary source.
No credit card. Cancel anytime.
Valuation elevated (forward P/E 38.2 vs sector 24.1) offsets strong revenue growth (122% YoY per latest 10-Q). With Fed funds at 5.33% and the 10Y at 4.38%, risk-asset multiples face compression. Wait for entry below $420 or for next earnings print.
Read-only sync via Plaid + SnapTrade. We never execute trades.
Claude, GPT, Gemini — each lens runs on a different vendor so no single blind spot becomes yours.
Every number traces back to its 10-Q, FRED series, or market feed. A supervisor rejects unverifiable claims.
Every brief is scored at 7d / 30d / 90d / 365d. The public track record shows hits and misses both.
Most investing tools give you opinions.
ClearPath gives you evidence.
A research desk for your portfolio.
Ingest
Pull live data from 12+ authoritative sources — SEC filings, Fed indicators, real prices. Nothing cached, nothing summarized.
Analyze
Three investment lenses — Quality, Momentum, Context — examine the same evidence in parallel. Each lens applies its own discipline; disagreement between them is surfaced, not hidden.
Verify
A supervisor cross-checks every claim against the source data. Unverifiable claims are flagged and stripped.
Deliver
A clear recommendation — BUY, HOLD, or SELL — with every supporting number traceable to its source.
We read the filings.
We verify the numbers.
Every recommendation references primary sources. Our analytics engine pulls live data straight from regulatory filings, official market feeds, and academic research databases — no black-box training data, no hedge-fund hearsay.
The honest comparison.
- ✗Answers pulled from stale training data
- ✗Single model, confident opinion
- ✗No citations, no traceability
- ✗Overfit to bull markets
- ✗Can’t tell you when it doesn’t know
- Live data from 12+ authoritative sources
- Three investment lenses — Quality, Momentum, Context — cross-examine the same evidence
- Every number traces to a primary source
- Bias toward HOLD when evidence is ambiguous
- Tells you exactly what it needs to be more confident
Ready for
considered decisions?
Start your free 30-day trial — full access, no credit card. Built for investors who want evidence, not vibes.
No credit card. Cancel anytime.